Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
暂无分享,去创建一个
D. Rimland | R. Kuykendall | M. McNeil | T. Lott | A. Espinel-Ingroff | D. Warnock | C. Elie | E. Reiss | W. Pruitt | M. Kellum | L. Gallagher | B. Lasker
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] J. Ward,et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[3] J. Rex,et al. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] T. Lott,et al. Rapid Identification of Candida Species with Species-Specific DNA Probes , 1998, Journal of Clinical Microbiology.
[5] S. Sanche,et al. Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates , 1998, Journal of Clinical Microbiology.
[6] R. Haubrich,et al. Random Amplification of Polymorphic DNA and Microsatellite Genotyping of Pre- and Posttreatment Isolates ofCandida spp. from Human Immunodeficiency Virus-Infected Patients on Different Fluconazole Regimens , 1998, Journal of Clinical Microbiology.
[7] S. Hammer,et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1998, JAMA.
[8] Kenji Tanaka,et al. Repetitive sequences (RPSs) in the chromosomes of Candida albicans are sandwiched between two novel stretches, HOK and RB2, common to each chromosome. , 1998, Microbiology.
[9] T. C. White,et al. Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.
[10] E. Anaissie,et al. Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.
[11] M. Pfaller,et al. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection , 1997, Journal of clinical microbiology.
[12] D. Soll,et al. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2 , 1996, Journal of clinical microbiology.
[13] C. Kauffman,et al. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus , 1994, Antimicrobial Agents and Chemotherapy.
[14] G. Reboux,et al. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype , 1994, Journal of clinical microbiology.
[15] J. Perfect,et al. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 , 1993, Antimicrobial Agents and Chemotherapy.
[16] B. Dupont,et al. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole , 1993, Journal of clinical microbiology.
[17] T. C. White,et al. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans , 1993, Journal of clinical microbiology.
[18] T. C. White,et al. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. , 1992, Journal of acquired immune deficiency syndromes.
[19] T. Lott,et al. Isolation, characterization, and sequencing of Candida albicans repetitive element 2. , 1992, Gene.
[20] D. Soll,et al. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting , 1992, Journal of clinical microbiology.
[21] D. Soll,et al. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification , 1991, Journal of bacteriology.
[22] D. Soll,et al. High-frequency switching in Candida strains isolated from vaginitis patients , 1987, Journal of clinical microbiology.
[23] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[24] S. Hume,et al. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[25] J. Wingard,et al. Importance of Candida species other than C. albicans as pathogens in oncology patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] M. Ashburner. A Laboratory manual , 1989 .